| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9170211 | Journal of Cardiac Failure | 2005 | 10 Pages |
Abstract
I-PRESERVE is the largest trial in this understudied area and will provide crucial information on the characteristics and course of the syndrome, as well as the efficacy of the angiotensin receptor blocker irbesartan.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Peter MD, Barry M. MD, Robert MD, PhD, John MD, Michel MD, Michael MD, Agata MD, Gerald MD, for the I-PRESERVE Investigators for the I-PRESERVE Investigators,